Patheon signs expanded manufacturing agreement with Merck & Co., Inc.
Patheon designated as a 'preferred supplier' to Merck
Patheon announced that it has signed an expanded contract manufacturing agreement with Merck & Co., Inc.
"We have developed a great partnership with Merck and are very pleased that they have chosen to expand it with this contract manufacturing agreement," said Wes Wheeler, Chief Executive Officer and President of Patheon Inc. "We are 100 percent focused on being the best service provider to our clients. This expanded contract with Merck validates that we are making great progress towards meeting this goal."
The expanded agreement solidifies Patheon as a key preferred supplier to Merck. Patheon's projects and services will be delivered to Merck from eight of Patheon's global facilities.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.